DYADIC INTERNATIONAL INC

Dyadic International, Inc., operating as Dyadic Applied BioSolutions, is a biotechnology company that develops, manufactures, and commercializes animal-free recombinant proteins and enzymes. The company utilizes its proprietary microbial expression platforms, Dapibus and C1, to produce precision-engineered proteins for research, diagnostics, cell culture media, functional food ingredients, and industrial biotechnology. Its offerings include cell culture reagents such as albumin, transferrin, and fibroblast growth factor, diagnostics products like DNase I, and food ingredients including caseins and lactoferrin. Dyadic serves customers and partners across the life sciences, food and nutrition, bio-industrial, and pharmaceutical sectors through direct product sales, distribution partnerships, manufacturing collaborations, and technology licensing agreements.

The company maintains corporate headquarters in Jupiter, Florida, and conducts operations in the United States along with a satellite office in the Netherlands. Its commercial activities and collaborative development partnerships involve international markets and various external contract research organizations.

Summary of the business section of Dyadic International's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“of December 31, 2025, the Company had 5 full-time employees, all of whom are located in the United States.”